BEIGF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BeOne Medicines AG

Watchlist Manager

Watchlist

Price: 21.946 USD

Market Cap: $2.5B

	BeOne Medicines AG OTC:BEIGF	CH
G	Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd F:GU5	CN
	Australian Industrial Minerals Ltd ASX:AAM	AU
G	Gen Digital Inc XHAN:SYM	US
	Dino Polska SA OTC:DNOPF	PL
S	Signet Jewelers Ltd SWB:SZ2	BM
S	Signet Jewelers Ltd F:SZ2	BM

Profitability Summary

BeOne Medicines AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

88%

Strong 3Y Average Gross Margin

85%

Gross Margin is Increasing

82% > 88%

Healthy Operating Margin

12%

Negative 3Y Average Operating Margin

-19%

Operating Margin is Increasing

-89% > 12%

Low Net Margin

Negative 3Y Average Net Margin

-17%

Net Margin is Increasing

-97% > 8%

Exceptional Free Cash Flow Margin

34%

Negative 3Y Average Free Cash Flow Margin

-20%

Free Cash Flow Margin is Increasing

-104% > 34%

Positive ROE

11%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-28%

ROIC is Increasing

-66% > 17%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.